A PROSPECTIVE RANDOMIZED TRIAL OF 5-FLUOROURACIL VERSUS 5-FLUOROURACIL AND HIGH-DOSE LEUCOVORIN VERSUS 5-FLUOROURACIL AND METHOTREXATE IN PREVIOUSLY UNTREATED PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA

被引：456

作者：

PETRELLI, N

HERRERA, L

RUSTUM, Y

BURKE, P

CREAVEN, P

STULC, J

EMRICH, LJ

MITTELMAN, A

机构：

[1] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT CLIN PHARMACOL,BUFFALO,NY 14263

[2] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT THERAPEUT,BUFFALO,NY 14263

[3] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT EXPTL THERAPEUT,BUFFALO,NY 14263

[4] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT BIOMATH,BUFFALO,NY 14263

来源：

关键词：

D O I：

10.1200/JCO.1987.5.10.1559

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1559 / 1565

页数：7

共 20 条

[1] ANSFIELD F, 1977, CANCER-AM CANCER SOC, V39, P34, DOI 10.1002/1097-0142(197701)39:1<34::AID-CNCR2820390107>3.0.CO
[2] 2-2
[3] BRUCKNER HW, 1983, P AM ASSOC CANC RES, V24, P138
[4] BYRNE P, 1983, P AM SOC CLIN ONCOL, V2, P121
[5] CUNNINGHAM J, 1984, INVEST NEW DRUG, V2, P391
[6] DAVIS HL, 1982, CANCER-AM CANCER SOC, V50, P2638
[7] CHEMOTHERAPY OF ADVANCED COLORECTAL-CARCINOMA - FLUOROURACIL ALONE VS 2 DRUG-COMBINATIONS USING FLUOROURACIL, HYDROXYUREA, SEMUSTINE, DACARBAZINE, RAZOXANE, AND MITOMYCIN - A PHASE-III TRIAL BY THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP (EST-1278)
ENGSTROM, PF
MACINTYRE, JM
MITTELMAN, A
KLAASSEN, DJ
[J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1984, 7 (04): : 313 - 318
[8] EVANS RM, 1981, CANCER RES, V41, P3283
[9] HEIDELBERGER C, 1975, HDB EXPT PHARMAKOLOG, V38, P193
[10] HOUGHTON JA, 1981, CANCER RES, V41, P144